Business Context and Reporting Period
This Form 8-K was filed by Zimmer Holdings, Inc. (now Zimmer Biomet Holdings, Inc.) on November 7, 2011. The report details the entry into a material definitive agreement regarding a public debt offering.
Key Financial Metrics
The filing discloses the issuance of two new series of notes with the following terms:
- 2014 Notes: $250.0 million aggregate principal amount; 1.400% interest rate per annum; matures November 30, 2014.
- 2021 Notes: $300.0 million aggregate principal amount; 3.375% interest rate per annum; matures November 30, 2021.
- Total Proceeds: $550.0 million aggregate principal amount.
- Interest Payments: Payable semi-annually in arrears on May 30 and November 30, commencing May 30, 2012.
The filing text does not provide specific values for revenue, profit, cash flow, operating margins, or existing liquidity positions, as this report focuses solely on the debt issuance event.
Material Changes
The primary material change is the creation of a direct financial obligation totaling $550.0 million. The offering closed on November 10, 2011. The company entered into an underwriting agreement with Merrill Lynch, Pierce, Fenner & Smith Incorporated, BNP Paribas Securities Corp., and RBS Securities Inc.
Outlook, Risks, and Unusual Items
Redemption Provisions: The Company may redeem the Notes in whole or in part at any time with 30 to 60 days' prior written notice. Specifically, the 2021 Notes may be redeemed on or after August 30, 2021, at 100% of the principal amount plus accrued interest.
Events of Default: The Supplemental Indenture includes customary events of default, including nonpayment, failure to comply with agreements for 90 days, and events of bankruptcy, insolvency, or reorganization.
Unusual Items: No unusual items or contingencies were disclosed in this filing beyond the standard terms of the debt issuance.
Investor Verification Checklist
- Verify the use of proceeds from the $550.0 million offering in the accompanying press releases (Exhibits 99.1 and 99.2).
- Review the "Computation of Ratio of Earnings to Fixed Charges" (Exhibit 12.1) to assess the impact of new interest obligations on leverage.
- Confirm the final closing date and net proceeds received after underwriting discounts and commissions.
- Examine the Supplemental Indenture (Exhibit 4.1) for specific covenants and restrictions on future indebtedness.